|
Delayed
Japan Exchange
10:30:00 09/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,353.00 JPY | -2.95% |
|
-5.33% | +8.31% |
| 09-02 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,106B 7.2B 6.2B 5.83B 5.32B 9.94B 685B 9.98B 69.14B 26.72B 349B 27.03B 26.45B | P/E 2027 * |
15.2x | P/E 2028 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 905B 5.89B 5.07B 4.77B 4.35B 8.14B 560B 8.17B 56.56B 21.86B 286B 22.12B 21.64B | EV / Sales 2027 * |
1.97x | EV / Sales 2028 * | 1.91x |
| Free-Float |
81.92% | Yield 2027 * |
3.32% | Yield 2028 * | 3.29% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Tradegate
| ON4 | Real-time | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Deutsche Boerse AG
| ON4 | Delayed |
Last Transcript : Ono Pharmaceutical Co., Ltd.
| 1 day | -2.95% | ||
| 1 week | -5.33% | ||
| Current month | -3.98% | ||
| 1 month | -1.16% | ||
| 3 months | +4.67% | ||
| 6 months | -6.66% | ||
| Current year | +8.31% |
| 1 week | 2,349 |  | 2,511 |
| 1 month | 2,349 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 01/04/2024 |
Masaki Ito
DFI | Director of Finance/CFO | - | 01/04/2026 |
Toichi Takino
PSD | President | 57 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 01/04/2024 |
Toichi Takino
BRD | Director/Board Member | 57 | 01/06/2020 |
Masao Nomura
BRD | Director/Board Member | 77 | 26/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.95% | -5.33% | +32.45% | -15.96% | 7.39B | |
| -1.11% | -3.32% | +17.96% | +64.97% | 47.73B | |
| -1.06% | -5.77% | +37.73% | +115.68% | 40.21B | |
| -1.58% | -3.46% | +11.66% | +79.48% | 12.05B | |
| -1.51% | -4.21% | -11.56% | +9.52% | 11.79B | |
| +0.38% | -1.32% | +21.40% | +137.27% | 9.16B | |
| 0.00% | -4.04% | +21.19% | +33.90% | 7.34B | |
| -1.60% | -1.43% | +18.67% | +213.45% | 7.37B | |
| +1.32% | -1.19% | -46.13% | +22.77% | 5.13B | |
| -1.25% | +0.84% | +36.43% | +104.11% | 4.72B | |
| Average | -0.94% | -1.54% | +13.98% | +76.52% | 15.29B | |
| Weighted average by Cap. | -1.06% | -2.52% | +19.90% | +81.04% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.99B 2.57B 2.42B 2.2B 4.12B 284B 4.14B 28.67B 11.08B 145B 11.21B 10.97B | 448B 2.92B 2.51B 2.37B 2.16B 4.03B 278B 4.05B 28.04B 10.84B 142B 10.96B 10.73B |
| Net income | 72.89B 475M 408M 385M 350M 656M 45.16B 658M 4.56B 1.76B 23.01B 1.78B 1.74B | 63.15B 411M 354M 333M 304M 568M 39.13B 570M 3.95B 1.53B 19.93B 1.54B 1.51B |
| Net Debt | -201B -1.31B -1.13B -1.06B -967M -1.81B -125B -1.82B -12.57B -4.86B -63.48B -4.92B -4.81B | -250B -1.63B -1.4B -1.32B -1.2B -2.25B -155B -2.25B -15.61B -6.03B -78.82B -6.11B -5.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | ¥2,353.00 | -2.95% | 1,354,600 |
| 08/09/26 | ¥2,424.50 | +0.25% | 1,218,900 |
| 07/09/26 | ¥2,418.50 | -1.23% | 1,201,300 |
| 04/09/26 | ¥2,448.50 | -1.67% | 1,559,800 |
| 03/09/26 | ¥2,490.00 | +0.81% | 1,481,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
